Kwangdong Pharmaceutical, Active Community... Stock Price Up 29.61%.

At this time, posts about Gwangdong Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreigners have sold a net 162,000 shares of Gwangdong Pharmaceutical, and institutions have sold a net 7,000 shares, according to provisional data. Gwangdong Pharmaceutical is known as a pharmaceutical company specializing in herbal products and health beverages.

As of 11:30 AM on the 3rd, Gwangdong Pharmaceutical's stock price is 13,350 KRW, up 29.61% from the previous day, with a trading volume of 23,595,578 shares, which is 1,472.11% of the 5-day average trading volume. On August 24, Gwangdong Pharmaceutical became an issue in the market with the news "Co-marketer ‘Betadine’ confirmed to inactivate COVID-19, leading to strength."

In addition to Gwangdong Pharmaceutical, posts by investors are also rapidly increasing for Kumho HT (214330), HanAll Biopharma (009420), and Newgelab (214870).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.